Having trouble accessing articles? Reset your cache.

Targacept's AZD1446 misses ADHD target

Targacept Inc. (NASDAQ:TRGT) said AZD1446 missed the primary endpoint of significantly improving

Read the full 128 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE